On this page

Prehevbrio

Hepatitis B Vaccine (Recombinant)

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Prehevbrio
Proper name
Hepatitis B Vaccine (Recombinant)
Licence type
351(a)
BLA number
125737
Applicant
VBI Vaccines (Delaware), Inc.
Center
CBER
Presentations
1
First licensure
November 30, 2021

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
10UG/ML For Injection Intramuscular Single-Dose Vial Disc November 30, 2021

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity